BSGIX
Small/Mid Cap Growth Fund
inception date
10/31/2018
cusip
057071540
total fund aum (millions)
$68.90
As of 8/31/2026
gross/net expense ratio %
0.93/0.85*
morningstar category
Mid-Cap Growth
What is the Baird Small/Mid Cap Growth Fund?
The Baird Small/Mid Cap Growth Fund is an actively managed U.S. equity fund focused on high-quality, small- and mid-cap growth companies. The Fund seeks long-term growth of capital by investing with a disciplined, long-term perspective and a strong emphasis on risk control. The investment team brings extensive experience in the asset class and applies a consistent, traditional growth approach that has remained grounded in the same investment principles across market cycles.
Performance
ALL DATA AS OF 8/31/2026
| 1 Month | 3 Month | YTD | 1 Year | 3 Years | 5 Years | Since Inception | |
|---|---|---|---|---|---|---|---|
| Small/Mid Cap Growth Fund | -0.79 | -1.27 | 4.00 | 1.87 | 1.38 | -3.72 | 7.29 |
| Russell 2500 Growth Index | 1.43 | -4.20 | 11.81 | 15.32 | 14.13 | 3.51 | 10.54 |
Portfolio Characteristics
ALL DATA AS OF 6/30/2026
| Security | % of Fund |
|---|---|
| Neurocrine Biosciences, Inc. | 3.19% |
| Curtiss-Wright Corporation | 3.17% |
| Twist Bioscience Corp. | 2.98% |
| Victoria's Secret & Company | 2.67% |
| Dutch Bros, Inc. Class A | 2.60% |
| FTAI Aviation Ltd. | 2.56% |
| Twilio, Inc. Class A | 2.45% |
| UL Solutions Inc. Class A | 2.23% |
| Woodward, Inc. | 2.19% |
| Lattice Semiconductor Corporation | 2.17% |
Documents
Regulatory Documents
Full Prospectus
Summary Prospectus
Statement of Additional Information
Semiannual Tailored Shareholder Report Investor Class
Semiannual Tailored Shareholder Report Institutional Class
Annual Tailored Shareholder Report Investor Class
Annual Tailored Shareholder Report Institutional Class
Equity Funds Semiannual Financial Statements and Other Information
Equity Funds Annual Financial Statements and Other Information
Schedule of Investments 3/31
Schedule of Investments 9/30